Cordlife launches newborn metabolic screening service in Hong Kong

Cordlife launches newborn metabolic screening service in Hong Kong

Michelle Zhu
02/05/18, 01:14 pm

SINGAPORE (May 2): HealthBaby Biotech (Hong Kong), a wholly-owned subsidiary of Cordlife Group, has launched a newborn metabolic screening service in Hong Kong.

This comes as part of Cordlife’s move to expand its diagnostics business, says the group in a press release issued on Wednesday.

Named Metascreen, the service uses urine instead of blood to detect over 100 inherited metabolic disorders – which is much more than what can be detected by conventional newborn metabolic screening tests currently available in Hong Kong, according to the group.

The specimens are taken from babies 48 hours after birth and up to six months old, and will be testing using an US-FDA-approved Gas Chromatography/Mass Spectrometry platform from Japan at the laboratory of Hong Kong Screening Centre, which is another subsidiary of Cordlife.

Aside from Metascreen being a non-invasive procedure, Cordlife emphasises that using urine as a test specimen is highly effective as metabolites tend to accumulate in urine first, while blood accumulation of toxic substances will only appear once the kidney clearance capacity is exceeded.

The group also says that Metascreen can provide “highly specific and definite results” as it analyses up to four analyte profiles to detect a single metabolic disorder – which helps to reduce false positive rates compared to conventional newborn metabolic screening, which usually only uses one or two analyte profiles in comparison.

“The launch of Metascreen by HealthBaby enables us to reach an even wider audience in Hong Kong. This will give more parents the opportunity to take proactive steps in enabling early detection, which can help avoid lifelong and potentially fatal effects of inborn errors of metabolism,” said Michael Weiss, Group CEO and Executive Director of Cordlife.

“New Cordlife is all about leveraging our extensive, multi-national platform to access large pockets of demand for all new offerings. We will continue to add innovative new services that can, to the greatest extent possible, be ‘plugged in and played’ across the entire system,” he adds.

As at 1.15pm, shares in Cordlife are trading flat at 70 cents.

6 protesters killed as Indonesia election rally turns violent

SINGAPORE (May 22): At least six people were killed and hundreds more injured in clashes between police and supporters of Indonesian presidential candidate Prabowo Subianto in the worst political violence to hit Jakarta in two decades. Jakarta Governor Anies Baswedan appealed for public order and urged police to exercise restraint and avoid conflict with the protesters in the capital city. About 200 injured protesters have been admitted to various hospitals in Jakarta, Baswedan told reporters. The violence is the worst since to grip the city since the downfall of Suharto in 1998. Protest....

Margins weak for Riverstone but expansion plans on track

SINGAPORE (May 22): With margins under pressure at Riverstone Holdings, analysts say growth recovery would only be seen after 1Q19 given its expansion plans are on track. In 1Q19, Riverstone reported revenue grew 14.6% on the back of a higher annual glove capacity of 9 billion from a year ago. However, net profit declined 2.8% y-o-y to RM30.2 million, which CGS-CIMB deemed slightly disappointing at 21.3%/20.7% of its/consensus’ FY19F forecasts. CGS-CIMB analyst Colin Tan says the decline was mainly due to a drop in ASPs for healthcare gloves and higher taxation as a result of higher....

Health Management International kept at 'buy' on healthy business, demographic shift and rising affluence

SINGAPORE (May 22): Phillip Capital, Maybank KimEng and UOB KayHian all have “buy” calls on Health Management International after 3Q19 revenue rose on the back of resilient patient load growth and increasing average patient bill size. In the third quarter, patient load grew 1.3% y-o-y to 116,200 patients, driven by both inpatient and outpatient growth from Mahkota Medical Centre (MMC), Melaka and Regency Specialist Hospital (RSH), Johor. See: Health Management International posts 15% drop in 3Q earnings to $4.4 mil on higher costs According to Phillip, HMI’s average inpatient an....